A detailed history of Tortoise Investment Management, LLC transactions in Gh Research PLC stock. As of the latest transaction made, Tortoise Investment Management, LLC holds 1,781 shares of GHRS stock, worth $14,835. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,781
Previous 1,781 -0.0%
Holding current value
$14,835
Previous $18,000 11.11%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 09, 2024

SELL
$5.34 - $11.09 $6,942 - $14,417
-1,300 Reduced 42.19%
1,781 $18,000
Q3 2022

Nov 04, 2022

SELL
$10.15 - $16.15 $10,150 - $16,149
-1,000 Reduced 24.5%
3,081 $36,000
Q2 2022

Aug 03, 2022

BUY
$8.99 - $19.87 $36,688 - $81,089
4,081 New
4,081 $41,000

Others Institutions Holding GHRS

About GH Research PLC


  • Ticker GHRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 52,020,800
  • Market Cap $433M
  • Description
  • GH Research PLC, a clinical-stage biopharmaceutical company, engages in developing various therapies for the treatment of psychiatric and neurological disorders. The company focuses on developing 5-Methoxy-N,N-Dimethyltryptamine (5-MeO-DMT) therapies for the treatment of patients with treatment-resistant depression (TRD). Its lead program is GH0...
More about GHRS
Track This Portfolio

Track Tortoise Investment Management, LLC Portfolio

Follow Tortoise Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tortoise Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Tortoise Investment Management, LLC with notifications on news.